可素优品(佛山)健康科技有限公司
20-99人

20,861+ 岗位更新等你来订阅
一键订阅最新的岗位,每周送达
🎉恭喜你,订阅成功
继续订阅您可以在邮箱中随时取消订阅
郑州博肤胎记研究院位于郑州市二七区航海中路齐礼阎六号院1号楼,是经卫生主管部门批准,按照国家相关标准设立的专家型胎记专科医院,隶属于博肤品牌旗下全国连锁的专业胎记机构,同时也是华中地区首家专注于儿童青少年胎记血管瘤诊疗的基地。
医院设有胎记、血管瘤等相关科室,专业诊治太田痣、咖啡牛奶斑、鲜红斑痣、血管瘤、色素痣以及褐青色痣、黑毛痣、皮脂腺痣、蓝痣等色素血管型胎记。此外,医院还设立了胎记医学影像中心、胎记医学检测中心、胎记医学光电中心、胎记B·R医学复色中心四大中心,年接诊量超过20000例,在全省范围内学术水平排名前三。
医院拥有专业的医疗团队,包括安海燕、张艳丽等知名胎记血管瘤专家,他们凭借丰富的经验和精湛的技术帮助众多患者摆脱胎记困扰。医院与中国医学科学院皮肤病医院(皮炎所)、北京协和医院、北京航空总医院、北京大学第三医院、北京积水潭医院、南京维多利亚医院等多家机构开展交流合作,针对复杂病例会定期邀请国内权威专家进行会诊讨论,为患者提供最优治疗方案。
医院掌握多项核心技术,如以色列飞顿、美国赛诺秀翠绿宝石激光、美国赛诺秀双波长激光平台等先进设备,用于全面应对各种皮肤色素性疾病的治疗。特别是双波长纳米光技术,能够高效治疗血管性疾病,有效软化底层血管,去除红胎记。近年来,医院引进并研发的多项先进技术显著提升了临床治愈率,其中纳米光治疗技术尤为突出,它可以在可视条件下实现对胎记的精细化处理,根据不同胎记类型选择适宜波长设备,具备穿透力强、创伤小、不易复发、并发症少的优点,深受患者欢迎。
截至2022年1月,博肤胎记研究院连锁机构累计接诊患者超过60万人次。作为华中地区专业的胎记血管瘤治疗品牌,博肤胎记不仅致力于科研与诊疗,还积极履行社会责任,不断推进胎记诊疗领域的规范化进程,并多次举办学术会议和技术推广活动,推动行业进步与发展。
**修订版:**
翔通国际贸易(上海)有限公司成立于2011年,是一家总部设于新加坡的外商独资企业,其母公司为HETAT Pte Ltd,隶属于新加坡上市公司SHS Holding Ltd集团。
公司在中国杭州萧山区建有钢结构加工基地,并获得新加坡钢结构协会颁发的S1钢结构制造认证证书,确保了其产品和服务的质量与专业性。
业务范围广泛,涵盖建筑幕墙、建筑钢结构以及室内装饰工程的咨询、设计、制造、工程管理和进出口贸易等多个领域,致力于为客户提供全方位、高质量的服务。
Leica Microsystems, one of the esteemed companies under the prestigious Danaher Corporation's umbrella, is a global pioneer in the realms of microscopes and scientific equipment. The company's journey began as a family business over 160 years ago in the 19th century, and it has since evolved into a global powerhouse, consistently driving innovation.
Headquartered in Wetzlar, Germany, Leica Microsystems boasts a global presence with offices in over 100 countries. It operates from 12 manufacturing sites across 7 countries and maintains sales and service entities in 20 countries, complemented by an extensive global distributor network.
Since its entry into the Chinese market in 1995, Leica Microsystems has adhered to its core principle of "Collaboration with customers for mutual benefit". This commitment, coupled with its industry-leading product performance and comprehensive solutions, has positioned it as a top-tier player in China's microscopy sector. Its operations span a range of sectors, including life science research, industry, and medical surgery.
By the end of 2013, Leica Microsystems had established 7 offices across China, with a robust sales and service network covering 16 regions, including Hong Kong. This network supported a significant annual revenue exceeding $100 million. The company also boasts a manufacturing base and research and development center in Shanghai, employing over 300 personnel and generating a production output of over $25 million annually.
For more information, please visit: [Company Website]